{"id":11215,"date":"2018-07-23T23:00:00","date_gmt":"2018-07-23T21:00:00","guid":{"rendered":"https:\/\/lombardialifesciences.it\/pubblicati-due-nuovi-bandi-15-e-16-da-imi-innovative-medicines-initiatives\/"},"modified":"2023-06-22T22:16:07","modified_gmt":"2023-06-22T20:16:07","slug":"pubblicati-due-nuovi-bandi-15-e-16-da-imi-innovative-medicines-initiatives","status":"publish","type":"post","link":"https:\/\/lombardialifesciences.it\/en\/pubblicati-due-nuovi-bandi-15-e-16-da-imi-innovative-medicines-initiatives\/","title":{"rendered":"Pubblicati due nuovi bandi (15\u00b0 e 16\u00b0) da IMI &#8211; Innovative Medicines Initiatives"},"content":{"rendered":"<p><p>La  Call 15 prevede la presentazione a due fasi di progetti su topic quali:<\/p>\n<ul>\n<li>Integrated research platforms enabling patient-centric drug development<\/li>\n<li>Blockchain enabled healthcare<\/li>\n<li>Microenvironment imposed signatures in tissue and liquid biopsies in immune-mediated diseases   <\/li>\n<li>Emerging translational safety technologies and tools for interrogating human immuno-biology<\/li>\n<li>Development and validation of translational platforms in support of synaptopathy drug discovery<\/li>\n<li>Digital endpoints in neurodegenerative and immune-mediated diseases<\/li>\n<\/ul>\n<p>La Call 16 prevede la presentazione a singola fase di proposte all\u2019interno del programma AMR.<\/p>\n<p>Le proposte devono essere presentate entro il <strong>24 ottobre 2018<\/strong>.<\/p>\n<p>Pewr maggiori informazioni va al <a href=\"https:\/\/www.imi.europa.eu\/news-events\/press-releases\/new-antimicrobial-resistance-accelerator-programme-part-latest-imi-calls\">link<\/a>.<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Call 15 prevede la presentazione a due fasi di progetti su topic quali: Integrated research platf&#8230;<\/p>\n","protected":false},"author":1,"featured_media":11216,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[44],"tags":[],"class_list":["post-11215","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/11215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/comments?post=11215"}],"version-history":[{"count":1,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/11215\/revisions"}],"predecessor-version":[{"id":16618,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/11215\/revisions\/16618"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media\/11216"}],"wp:attachment":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media?parent=11215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/categories?post=11215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/tags?post=11215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}